Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-130280

Xenbase Image ID: 130280

Figure S8. CST Is Required for Proper Cell Growth of Cardiomyocytes Dorsal to the Cardiac Ventral Midline (A) Representative transverse sections of Stage 29 control MO (top) and CstMO (bottom) injected embryos stained with MHC antibody to mark differentiated cardiomyocytes, phospho-histone H3 (pH3) antibody to mark cardiac cells in the Mphase of the cell cycle, and DAPI. Bracket highlights undifferentiated cardiac ventral midline cells. (B) CST-depleted differentiated cardiomyocytes have an increased mitotic index at Stage 29. Quantification of the mitotic index was determined by calculating the percentage of pH3-positive differentiated cardiomyocytes. Bars represent the average of at least three embryos per condition +/- SEM. *, p<0.01; Scale bars: 200 μm.

Image published in: Christine KS and Conlon FL (2008)

Copyright © 2008. Image reproduced with permission of the Publisher, Elsevier B. V.

GeneSynonymsSpeciesStage(s)Tissue
h3-3a.Lh3.3, h3.3a, h3f3aX. laevisThroughout NF stage 29 and 30heart
myh6.LaMHC, ck231, MHC, MHC-alpha, MHCa, MHCalpha, muz, muzak, XCMHCX. laevisThroughout NF stage 29 and 30heart
cardiac myocyte

Image source: Published

Larger Image
Printer Friendly View

Return to previous page